Cargando…
Mucopolysaccharidoses diagnosis in the era of enzyme replacement therapy in Egypt
BACKGROUND: Undegraded glycosaminoglycans (GAGs) induced by deficiency of enzymes are the primary cause of mucopolyscchardoses. Mucopolysacchardoses (MPS) are a group of rare lysosomal storage diseases (LSD). The quantification of a specific enzymatic activity is needed for accurate diagnosis. The o...
Autores principales: | Fateen, Ekram, Abdallah, Zeinab Y., Nazim, Walaa S., Ibrahim, Mona, Radwan, Amira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387752/ https://www.ncbi.nlm.nih.gov/pubmed/34471711 http://dx.doi.org/10.1016/j.heliyon.2021.e07830 |
Ejemplares similares
-
Novel Enzyme Replacement Therapies for Neuropathic Mucopolysaccharidoses
por: Sato, Yuji, et al.
Publicado: (2020) -
Difficulties Associated with Enzyme Replacement Therapy for Mucopolysaccharidoses
por: Yıldız, Yılmaz, et al.
Publicado: (2021) -
Twenty- five years of biochemical diagnosis of Gaucher disease: the Egyptian experience
por: Fateen, Ekram, et al.
Publicado: (2019) -
Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations
por: Parini, Rossella, et al.
Publicado: (2020) -
Progression of Cardiovascular Manifestations in Adults and Children With Mucopolysaccharidoses With and Without Enzyme Replacement Therapy
por: Poswar, Fabiano de Oliveira, et al.
Publicado: (2022)